Cagrilintide — Long-Acting Amylin Analogue for Obesity Research
Cagrilintide is a fatty acid-acylated long-acting amylin analogue developed by Novo Nordisk, designed for once-weekly dosing in obesity research protocols. Amylin is a pancreatic hormone co-secreted with insulin that promotes satiety via the area postrema and brainstem — a pathway distinct from and complementary to GLP-1. When combined with Semaglutide (CagriSema), Phase 3 data has approached 25%+ body weight reduction.
Available Formats
- 10mg
- 5mg
Reconstitution: Reconstitute with Bacteriostatic Water (BAC Water) for multi-use stability, or Sterile Water for single-use protocols. Store lyophilized vials at 2–8°C.
Key Research Areas
⚡ Amylin Receptor Satiety Pathways
Cagrilintide activates amylin receptors in the area postrema and nucleus tractus solitarius — a central satiety circuit independent of GLP-1. Research demonstrates reduced food intake, slowed gastric emptying, and reduced postprandial glucagon — all contributing to sustained negative energy balance.
🔗 Synergy with GLP-1 Agonists (CagriSema)
REDEFINE phase 3 trial combining Cagrilintide 2.4mg with Semaglutide 2.4mg (CagriSema) is targeting 25%+ body weight reduction — potentially exceeding any single-compound approach. This dual pathway combination is a leading edge of obesity research.
🩸 Glycaemic Regulation
Amylin analogue activity suppresses inappropriate postprandial glucagon, slows gastric emptying, and may improve beta cell function — supporting complementary glycaemic research alongside GLP-1 protocols.
🦴 Bone & Weight Maintenance Research
Early data suggests amylin receptor activity may help preserve bone mineral density during significant weight loss — a critical research question in obesity pharmacology.
Why Choose EhBuddy?
- ✅ Verified Purity — Third-party tested for identity and potency
- ✅ Fast Canadian Shipping — Discreet packaging, shipped from Canada
- ✅ Research-Grade Quality — Strict manufacturing quality standards
FOR RESEARCH USE ONLY (RUO). Not approved for human or veterinary use. Intended for in vitro and laboratory research only. EhBuddy Peptides assumes no liability for misuse.













Reviews
There are no reviews yet.